Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

W E Hautz

Showing results (1-10 of 3) with videos related to

Pageof 1
Sort By:
BMC Emergency Medicine|June 21, 2022
Virtual Reality for Pain Relief in the Emergency Room (VIPER) - a prospective, interventional feasibility studyT Birrenbach, F Bühlmann, A K Exadaktylos, et al.
International Journal of Emergency Medicine|October 6, 2023
Development and usability testing of a fully immersive VR simulation for REBOA trainingT Birrenbach, R Wespi, W E Hautz, et al.
Clinical Otolaryngology : Official Journal of ENT-UK ; Official Journal of Netherlands Society for Oto-Rhino-Laryngology & Cervico-Facial Surgery|May 17, 2017
Epistaxis in anticoagulated patients: Fewer hospital admissions and shorter hospital stays on rivaroxaban compared to phenprocoumonT C Sauter, K Hegazy, W E Hautz, et al.
Pageof 1

Showing results (1-10 of 3) with videos related to

Sort By:
Pageof 1
BMC Emergency Medicine|June 21, 2022
Virtual Reality for Pain Relief in the Emergency Room (VIPER) - a prospective, interventional feasibility studyT Birrenbach, F Bühlmann, A K Exadaktylos, et al.
International Journal of Emergency Medicine|October 6, 2023
Development and usability testing of a fully immersive VR simulation for REBOA trainingT Birrenbach, R Wespi, W E Hautz, et al.
Clinical Otolaryngology : Official Journal of ENT-UK ; Official Journal of Netherlands Society for Oto-Rhino-Laryngology & Cervico-Facial Surgery|May 17, 2017
Epistaxis in anticoagulated patients: Fewer hospital admissions and shorter hospital stays on rivaroxaban compared to phenprocoumonT C Sauter, K Hegazy, W E Hautz, et al.
Pageof 1